Search

Mark V. Stevens

Examiner (ID: 4010, Phone: (571)270-7080 , Office: P/1613 )

Most Active Art Unit
1613
Art Unit(s)
1613
Total Applications
923
Issued Applications
533
Pending Applications
139
Abandoned Applications
300

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17733152 [patent_doc_number] => 20220218611 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS [patent_app_type] => utility [patent_app_number] => 17/702608 [patent_app_country] => US [patent_app_date] => 2022-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19513 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -59 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702608 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/702608
LIPID VESICLE COMPOSITIONS WITH PENETRATION ENHANCING AGENTS Mar 22, 2022 Pending
Array ( [id] => 17685662 [patent_doc_number] => 20220192954 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-23 [patent_title] => DELIVERY OF SURFACTANT SOLUBLE ANTI-DANDRUFF AGENT [patent_app_type] => utility [patent_app_number] => 17/694270 [patent_app_country] => US [patent_app_date] => 2022-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15582 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 131 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17694270 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/694270
DELIVERY OF SURFACTANT SOLUBLE ANTI-DANDRUFF AGENT Mar 13, 2022 Pending
Array ( [id] => 17836334 [patent_doc_number] => 20220273639 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => PROCESSES FOR PREPARING ARIMOCLOMOL CITRATE AND INTERMEDIATES THEREOF [patent_app_type] => utility [patent_app_number] => 17/691989 [patent_app_country] => US [patent_app_date] => 2022-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45862 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17691989 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/691989
Processes for preparing arimoclomol citrate and intermediates thereof Mar 9, 2022 Issued
Array ( [id] => 18056396 [patent_doc_number] => 20220387482 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-08 [patent_title] => PERFORMANCE ENHANCEMENT DELIVERY SYSTEM [patent_app_type] => utility [patent_app_number] => 17/803148 [patent_app_country] => US [patent_app_date] => 2022-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3783 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17803148 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/803148
PERFORMANCE ENHANCEMENT DELIVERY SYSTEM Mar 3, 2022 Abandoned
Array ( [id] => 19777499 [patent_doc_number] => 12226520 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-02-18 [patent_title] => Self-fueled particles for propulsion through flowing aqueous fluids [patent_app_type] => utility [patent_app_number] => 17/687364 [patent_app_country] => US [patent_app_date] => 2022-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 18 [patent_no_of_words] => 6104 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17687364 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/687364
Self-fueled particles for propulsion through flowing aqueous fluids Mar 3, 2022 Issued
Array ( [id] => 19232051 [patent_doc_number] => 20240189242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME [patent_app_type] => utility [patent_app_number] => 18/277346 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277346 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277346
LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME Feb 17, 2022 Pending
Array ( [id] => 19232051 [patent_doc_number] => 20240189242 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME [patent_app_type] => utility [patent_app_number] => 18/277346 [patent_app_country] => US [patent_app_date] => 2022-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47393 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18277346 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/277346
LIPID NANOPARTICLE COMPOSITIONS AND METHODS OF FORMULATING THE SAME Feb 17, 2022 Pending
Array ( [id] => 17889763 [patent_doc_number] => 11452710 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-09-27 [patent_title] => Micronutrient and plant extract composition and method of improving bone health [patent_app_type] => utility [patent_app_number] => 17/674146 [patent_app_country] => US [patent_app_date] => 2022-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5886 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17674146 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/674146
Micronutrient and plant extract composition and method of improving bone health Feb 16, 2022 Issued
Array ( [id] => 19209621 [patent_doc_number] => 11998659 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-06-04 [patent_title] => Bioimplant with evanescent coating film [patent_app_type] => utility [patent_app_number] => 17/673651 [patent_app_country] => US [patent_app_date] => 2022-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6294 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17673651 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/673651
Bioimplant with evanescent coating film Feb 15, 2022 Issued
Array ( [id] => 17944338 [patent_doc_number] => 20220331355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA [patent_app_type] => utility [patent_app_number] => 17/589838 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22627 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -34 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17589838 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/589838
PHARMACEUTICAL PREPARATIONS AND METHODS TO MANAGE WEIGHT AND TO MODULATE THE GUT MICROBIOTA Jan 30, 2022 Abandoned
Array ( [id] => 19570215 [patent_doc_number] => 20240374507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-11-14 [patent_title] => COMPOSITIONS, DEVICES AND METHODS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE [patent_app_type] => utility [patent_app_number] => 18/274125 [patent_app_country] => US [patent_app_date] => 2022-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37069 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18274125 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/274125
COMPOSITIONS, DEVICES AND METHODS FOR INDUCING ANTIGEN-SPECIFIC IMMUNE TOLERANCE Jan 25, 2022 Pending
Array ( [id] => 17790269 [patent_doc_number] => 20220249360 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-11 [patent_title] => Dedifferentiated cell extract of Bletilla and method for whitening, anti-oxidation and anti-wrinkling applying the same, and cosmetic comprising the same [patent_app_type] => utility [patent_app_number] => 17/584691 [patent_app_country] => US [patent_app_date] => 2022-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7966 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17584691 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/584691
Dedifferentiated cell extract of Jan 25, 2022 Issued
Array ( [id] => 19032376 [patent_doc_number] => 20240082191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/273694 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24387 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273694 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/273694
TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS Jan 23, 2022 Pending
Array ( [id] => 18747058 [patent_doc_number] => 11806348 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate [patent_app_type] => utility [patent_app_number] => 17/582516 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7914 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582516 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/582516
Methods of treatment using pharmaceutical capsule compositions comprising lumateperone mono-tosylate Jan 23, 2022 Issued
Array ( [id] => 19032376 [patent_doc_number] => 20240082191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/273694 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24387 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273694 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/273694
TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS Jan 23, 2022 Pending
Array ( [id] => 19032376 [patent_doc_number] => 20240082191 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-14 [patent_title] => TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS [patent_app_type] => utility [patent_app_number] => 18/273694 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24387 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18273694 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/273694
TOPICAL FORMULATION CONTAINING MODIFIED PHOSPHOLIPID COMPOUNDS Jan 23, 2022 Pending
Array ( [id] => 17958512 [patent_doc_number] => 20220339092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-27 [patent_title] => COSMETIC COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/569715 [patent_app_country] => US [patent_app_date] => 2022-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17979 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17569715 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/569715
Cosmetic compositions and methods Jan 5, 2022 Issued
Array ( [id] => 17759844 [patent_doc_number] => 20220233456 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => METHODS AND COMPOSITIONS PARTICULARLY FOR TREATMENT OF ATTENTION DEFICIT DISORDER [patent_app_type] => utility [patent_app_number] => 17/647149 [patent_app_country] => US [patent_app_date] => 2022-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14034 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17647149 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/647149
Methods and compositions particularly for treatment of attention deficit disorder Jan 4, 2022 Issued
Array ( [id] => 17702846 [patent_doc_number] => 20220202852 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => METHODS AND COMPOSITIONS OF AQUEOUS HYPOBROMOUS ACID FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/565348 [patent_app_country] => US [patent_app_date] => 2021-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4977 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -24 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17565348 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/565348
METHODS AND COMPOSITIONS OF AQUEOUS HYPOBROMOUS ACID FOR THE TREATMENT AND PREVENTION OF INFLAMMATORY CONDITIONS Dec 28, 2021 Abandoned
Array ( [id] => 19018802 [patent_doc_number] => 20240074973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-03-07 [patent_title] => PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF [patent_app_type] => utility [patent_app_number] => 18/269474 [patent_app_country] => US [patent_app_date] => 2021-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12705 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18269474 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/269474
PHARMACEUTICAL COMPOSITION FOR TOPICAL ADMINISTRATION CONTAINING EPI-NASTINE OR SALT THEREOF Dec 22, 2021 Pending
Menu